The Myriad myRisk® Hereditary Cancer test is a 35-gene panel that identifies an elevated risk for eight hereditary cancers: Breast, Ovarian, Gastric, Colorectal, Pancreatic, Melanoma, Prostate, Endometrial. One key feature is the test result that providers and patients receive. Instead of a test result indicating only whether the patient is positive or negative for a gene mutation, the myRisk test provides a clinical decision support tool. This tool outlines patients’ cancer risks and the medical management recommendations endorsed by societal guidelines.
Breast Cancer, Colorectal Cancer, Endometrial Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer
APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), BARD1 (BRCA1 Associated RING Domain 1), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1)
See More ...
Next-Generation Sequencing (NGS)